PMID- 29199404
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20191120
IS  - 2233-6079 (Print)
IS  - 2233-6087 (Electronic)
IS  - 2233-6079 (Linking)
VI  - 42
IP  - 1
DP  - 2018 Feb
TI  - Improvement of Glycosylated Hemoglobin in Patients with Type 2 Diabetes Mellitus 
      under Insulin Treatment by Reimbursement for Self-Monitoring of Blood Glucose.
PG  - 28-42
LID - 10.4093/dmj.2018.42.1.28 [doi]
AB  - BACKGROUND: In Korea, the costs associated with self-monitoring of blood glucose 
      (SMBG) for patients with type 2 diabetes mellitus (T2DM) under insulin treatment 
      have been reimbursed since November 2015. We investigated whether this new 
      reimbursement program for SMBG has improved the glycemic control in the 
      beneficiaries of this policy. METHODS: Among all adult T2DM patients with >/=3 
      months of reimbursement (n=854), subjects without any changes in 
      anti-hyperglycemic agents during the study period were selected. The improvement 
      of glycosylated hemoglobin (HbA1c) was defined as an absolute reduction in HbA1c 
      >/=0.6% or an HbA1c level at follow-up <7%. RESULTS: HbA1c levels significantly 
      decreased from 8.5%+/-1.3% to 8.2%+/-1.2% during the follow-up (P<0.001) in all the 
      study subjects (n=409). Among them, 35.5% (n=145) showed a significant 
      improvement in HbA1c. Subjects covered under the Medical Aid system showed a 
      higher prevalence of improvement in HbA1c than those with medical insurance 
      (52.2% vs. 33.3%, respectively, P=0.012). In the improvement group, the baseline 
      HbA1c (P<0.001), fasting C-peptide (P=0.016), and daily dose of insulin/body 
      weight (P=0.024) showed significant negative correlations with the degree of 
      HbA1c change. Multivariate analysis showed that subjects in the Medical Aid 
      system were about 2.5-fold more likely to improve in HbA1c compared to those with 
      medical insurance (odds ratio, 2.459; 95% confidence interval, 1.138 to 5.314; 
      P=0.022). CONCLUSION: The reimbursement for SMBG resulted in a significant 
      improvement in HbA1c in T2DM subjects using insulin, which was more prominent in 
      subjects with poor glucose control at baseline or covered under the Medical Aid 
      system.
CI  - Copyright (c) 2018 Korean Diabetes Association
FAU - Song, Young Shin
AU  - Song YS
AD  - Department of Internal Medicine, Seoul National University College of Medicine, 
      Seoul, Korea.
FAU - Koo, Bo Kyung
AU  - Koo BK
AD  - Department of Internal Medicine, Seoul National University College of Medicine, 
      Seoul, Korea.
AD  - Department of Internal Medicine, Seoul Metropolitan Government Boramae Medical 
      Center, Seoul, Korea.
AD  - Center for Medical Informatics, Seoul Metropolitan Government Boramae Medical 
      Center, Seoul, Korea.
FAU - Kim, Sang Wan
AU  - Kim SW
AD  - Department of Internal Medicine, Seoul National University College of Medicine, 
      Seoul, Korea.
AD  - Department of Internal Medicine, Seoul Metropolitan Government Boramae Medical 
      Center, Seoul, Korea.
FAU - Yi, Ka Hee
AU  - Yi KH
AD  - Department of Internal Medicine, Seoul National University College of Medicine, 
      Seoul, Korea.
AD  - Department of Internal Medicine, Seoul Metropolitan Government Boramae Medical 
      Center, Seoul, Korea.
FAU - Shin, Kichul
AU  - Shin K
AD  - Department of Internal Medicine, Seoul Metropolitan Government Boramae Medical 
      Center, Seoul, Korea.
AD  - Center for Medical Informatics, Seoul Metropolitan Government Boramae Medical 
      Center, Seoul, Korea.
FAU - Moon, Min Kyong
AU  - Moon MK
AUID- ORCID: 0000-0002-5460-2846
AD  - Department of Internal Medicine, Seoul National University College of Medicine, 
      Seoul, Korea.
AD  - Department of Internal Medicine, Seoul Metropolitan Government Boramae Medical 
      Center, Seoul, Korea. mkmoon@snu.ac.kr.
LA  - eng
PT  - Journal Article
DEP - 20170928
PL  - Korea (South)
TA  - Diabetes Metab J
JT  - Diabetes & metabolism journal
JID - 101556588
PMC - PMC5842298
OTO - NOTNLM
OT  - Blood glucose self-monitoring
OT  - Diabetes mellitus, type 2
OT  - Hemoglobin A, glycosylated
OT  - Insurance, health, reimbursement
COIS- No potential conflict of interest relevant to this article was reported.
EDAT- 2017/12/05 06:00
MHDA- 2017/12/05 06:01
PMCR- 2018/02/01
CRDT- 2017/12/05 06:00
PHST- 2017/05/03 00:00 [received]
PHST- 2017/08/07 00:00 [accepted]
PHST- 2017/12/05 06:00 [pubmed]
PHST- 2017/12/05 06:01 [medline]
PHST- 2017/12/05 06:00 [entrez]
PHST- 2018/02/01 00:00 [pmc-release]
AID - 41.e20 [pii]
AID - 10.4093/dmj.2018.42.1.28 [doi]
PST - ppublish
SO  - Diabetes Metab J. 2018 Feb;42(1):28-42. doi: 10.4093/dmj.2018.42.1.28. Epub 2017 
      Sep 28.